Back to Search

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

Paper Details
Authors:
Ludwig Kappos
David Li
Peter A. Calabresi
Paul O’Connor
Amit Bar‐Or
Frederik Barkhof
Ming Yin
David Leppert
Robert Glanzman
Jeroen Tinbergen
Stephen L. Hauser
Publication Date: 2011-11-01
Multiple Sclerosis Research StudiesMedicinePathology and Forensic MedicineHealth Sciences
Access Restricted

This paper is not available under open access. The publisher restricts full-text distribution.

You may still be able to access it through your institution, request it directly from the author, or view the abstract and citation details.

External Resources

Paper information is provided by public research databases. Summaries are generated to aid understanding and may not reflect the complete scope of the work. For the authoritative version, please refer to the original publication.